| | | | | |  | | WELCOME TO DEVICE TECHNOLOGIES Device Technologies is a major supplier of leading edge medical equipment and consumables to hospitals and healthcare professionals throughout Australia and New Zealand. As an independent company we are able to source and supply the most technologically advanced medical devices and to support these with professional services and training. PROUD SPONSORS OF THE CANCER.VIVE RIDE  Device Technologies was proud to sponsor the inaugural Cancer.vive Ride. The ride, held in South Africa, sees cancer survivors taking to the open road on motorbikes to rural communities and small towns to raise awareness about early detection, prevention and treatment of especially the shy cancers. These cancers often go undetected because of fear, stigmas, cultural taboos and lack of knowledge. The shy cancers include breast, ovarian, testicular, prostate and colo-rectal cancer. Click for more > |  | | To deliver superior health outcomes by providing patient access to the best medical systems available worldwide. | |  | | | | |  | | | | | | | | | |  | 14/05/2012 Ellanse Press Release Ellansé™ dermal filler Family has received market approval for Australia.
(Always read the lable. Use only as directed. If symptoms persist see your healthcare professional) | | | | | | | |  | 08/03/2011 Detail is in the Device In this article, published in Australian Advanced Aesthetics first issue of 2011, Device Technologies Plastic & Aesthetic General Manager, Brett McLachlan, discusses the developments in the industry and the next steps forward for Device Technologies. | | | |  | 05/03/2013 An Inspiring Story “Perfect Scars – An exploration of the emotional and physical impact of breast cancer”
is a book of inspiring stories that addresses negative perceptions that often surround breast cancer | | | |  | Proud sponsors of the inaugural Cancer.vive Ride The ride, held in South Africa, sees cancer survivors taking to the open road on motorbikes to rural communities and small towns to raise awareness about early detection, prevention and treatment of especially the shy cancers. | | | | | |
| | | |
| |